Nanjing, China

Yong Chen

This inventor holds 31 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 1 EPO patent, primarily in Display Technology. Top assignees: Huawei Technologies Co., Limited, Nanjing Tech University, Nanjing University of Technology. Active years: 2014-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yong Chen. Retrieved from https://idiyas.com/inventor/yong-chen-atqau6ax

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 31 

% Patents Active = 80.6

 

 

Average Co-Inventor Count = 3.7

ph-index = 2

Forward Citations = 19(Granted Patents)


Location History:

  • Xi'an, CN (2020)
  • Jiangsu, CN (2020 - 2021)
  • Chengdu, CN (2023)
  • Nanjing, CN (2014 - 2024)
  • Wuhan, CN (2019 - 2024)

Company Filing History:


Years Active: 2014-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Display Panel
Flexible Display
Pixel Circuit
Manufacturing Method
Information Transmission
Device Capability Discovery
Exosomal microRNA
Anti-Tumor Effect
Lysine Production
Microbial Production
Substation Protection
Connector Technology
31 patents (USPTO):Explore Patents

Title: **Yong Chen: Innovator in Anti-Tumor Compounds and Display Technology**

Introduction

Yong Chen, an accomplished inventor based in Nanjing, China, has made significant contributions to the fields of pharmaceuticals and technology. With a remarkable portfolio of 29 patents, Chen exemplifies dedication and innovation in addressing complex challenges within these industries.

Latest Patents

Among his latest inventions, Chen has developed a **cordycepin-based derivatized compound with anti-tumor effect**. This innovative compound demonstrates an impressive capacity to inhibit tumor proliferation, showing enhanced affinity to cell membranes compared to the parent drug. Its longer half-life allows for prolonged presence in the body, providing better therapeutic outcomes with fewer side effects across a broader range of cancers, including gastric, pancreatic, liver, small cell lung, colorectal, melanoma, and ovarian cancers.

Furthermore, Chen has introduced a **display panel and its manufacturing method**, featuring a novel substrate and metal shielding layer that improves display performance through electric shielding principles. This advancement promises to elevate display technology, reducing interference from alternating current signals.

Career Highlights

Yong Chen has worked with prestigious organizations such as Huawei Technologies Co., Limited and Nanjing Tech University. His tenure at these institutions has solidified his position as a leader in innovation, where his research and developments have gained considerable recognition.

Collaborations

Throughout his career, Chen has collaborated with notable coworkers including Hanjie Ying and Jinglan Wu. These partnerships have contributed to the successful development of his patents and advanced his research initiatives, further enriching the field with valuable insights and discoveries.

Conclusion

In summary, Yong Chen’s contributions to innovation, particularly in anti-tumor compounds and display technology, underscore his role as a pivotal figure in the field. His body of work not only showcases his ingenuity but also provides promising solutions that can potentially transform healthcare and technology. As he continues to explore new frontiers, the impact of his inventions is sure to resonate in the industries he serves.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…